Opaleye Management’s BioLineRX BLRX Stock Holding History

Opaleye Management’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-417	Closed	-$16K	–	41
2022 Q3	$16K	Hold	417	–	–	0.01%	42
2022 Q2	$21K	Hold	417	–	–	0.01%	47
2022 Q1	$29K	Hold	417	–	–	0.01%	45
2021 Q4	$34K	Hold	417	–	–	0.01%	39
2021 Q3	$46K	Hold	417	–	–	0.01%	48
2021 Q2	$47K	Hold	417	–	–	0.01%	48
2021 Q1	$47K	Hold	417	–	–	0.01%	58
2020 Q4	$42K	Hold	417	–	–	0.01%	59
2020 Q3	$33K	Hold	417	–	–	0.01%	54
2020 Q2	$29K	Hold	417	–	–	0.01%	48
2020 Q1	$22K	Hold	417	–	–	0.01%	44
2019 Q4	$38K	Hold	417	–	–	0.01%	47
2019 Q3	$44K	Hold	417	–	–	0.02%	48
2019 Q2	$91K	Hold	417	–	–	0.03%	43
2019 Q1	$108K	Hold	417	–	–	0.03%	53
2018 Q4	$109K	Hold	417	–	–	0.04%	47
2018 Q3	$267K	Hold	417	–	–	0.07%	47
2018 Q2	$222K	Hold	417	–	–	0.06%	36
2018 Q1	$214K	Hold	417	–	–	0.06%	38
2017 Q4	$272K	Hold	417	–	–	0.09%	35
2017 Q3	$280K	Hold	417	–	–	0.1%	34
2017 Q2	$212K	Hold	417	–	–	0.09%	41
2017 Q1	$240K	Hold	417	–	–	0.12%	44
2016 Q4	$230K	Hold	417	–	–	0.14%	39
2016 Q3	$288K	Hold	417	–	–	0.15%	43
2016 Q2	$223K	Hold	417	–	–	0.15%	49
2016 Q1	$255K	Hold	417	–	–	0.16%	51
2015 Q4	$325K	Hold	417	–	–	0.14%	53
2015 Q3	$383K	Hold	417	–	–	0.19%	48
2015 Q2	$495K	Hold	417	–	–	0.2%	42
2015 Q1	$528K	Hold	417	–	–	0.25%	35
2014 Q4	$405K	Sell	417 -400	-49%	-$348K	0.2%	36
2014 Q3	$755K	Sell	817 -266	-25%	-$286K	0.59%	29
2014 Q2	$1.35M	Sell	1,083 -1,335	-55%	-$1.67M	1.17%	21
2014 Q1	$3.24M	Buy	2,418 +1,230	+104%	+$2.02M	2.39%	14
2013 Q4	$2.07M	Buy	+1,188	New	+$1.91M	1.62%	18

Other funds holding BLRX

ACM

Altium Capital Management New York $42M AUM

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GWM

Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

BAM

Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return

Opaleye Management's BLRX Position: Q4 2022 in Review

Opaleye Management sold out of BioLineRX (BLRX) in Q4 2022, closing a stake of 417 shares — an estimated $16K sold.

Opaleye Management first reported a position in BLRX in Q4 2013 and held it in 36 quarters. The position peaked at $3.24M in Q1 2014. 18 funds tracked by Wall St. Rank hold BLRX as of Q4 2022.

Opaleye Management reported no remaining BioLineRX position as of Q4 2022 after selling out during the quarter.
Opaleye Management sold 417 BioLineRX shares in Q4 2022, an estimated $16K.
Opaleye Management first reported a position in BioLineRX in Q4 2013 and held it in 36 quarters.
Opaleye Management's BioLineRX position peaked at $3.24M in Q1 2014.
18 funds tracked by Wall St. Rank held BioLineRX as of Q4 2022.

Based on Opaleye Management's 13F filing for Q4 2022, filed 10 Feb 2023.